Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
Shares of Regeneron Pharmaceuticals Inc. slipped 4.06% to $634.14 Tuesday, on what proved to be an all-around favorable ...
Is Ionis Pharmaceuticals, Inc. (IONS) a Promising Biotech Stock According to Wall Street Analysts
We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...
PNC Financial Services Group Inc. Grows Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
PNC Financial Services Group Inc. lifted its position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report ...
Maintaining An 'Accumulate' Rating On Mirum Pharmaceuticals, Lots To Like
Mirum Pharmaceuticals, Inc. shows strong growth with a 43% revenue jump and promising pipeline assets. Click here for my ...
Victory Capital Management Inc. Makes New Investment in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)
Victory Capital Management Inc. purchased a new stake in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) ...
American Association of Individual Investors5d
Why Telomir Pharmaceuticals, Inc.’s (TELO) Stock Is Up 11.76%
Telomir Pharmaceuticals, Inc.’s TELO share price has surged by 11.76%, which has investors questioning if this is right time ...
CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme
Berubicin showed clinically relevant outcomes comparable to Lomustine across multiple endpoints, but not a statistically ...
Glenmark Pharmaceuticals Launches Pioneering Nutrition Program to Fight Malnutrition in the Philippines
Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health ...
API maker Granules Pharma simplifies structure involving US subsidiaries
The exercise is aimed at reducing legal entities and simplify operating structure, said Granules Pharma, and the plan is expected to reduce the number of legal entities, simplify operational ...
X4 Pharmaceuticals: Q4 Earnings Snapshot
X4 Pharmaceuticals, Inc. (XFOR) on Tuesday reported a loss of $39.8 million in its fourth quarter. On a per-share basis, the Boston-based company said it had a loss of ...